2021
DOI: 10.1016/j.cobme.2021.100309
|View full text |Cite
|
Sign up to set email alerts
|

State of the art in integrated biosensors for organ-on-a-chip applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
43
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 51 publications
(43 citation statements)
references
References 38 publications
0
43
0
Order By: Relevance
“…Additional challenges biosensors incorporation in MPSs are scalability, biofouling, and reliability that should be addressed. [ 234 ] The combination of active materials and off‐chip detection systems that exclude the use of invasive probes could be a viable option. For example, nitrogen‐vacancy centers (NV) in diamonds are used for noninvasive and noncontact broadband vector magnetic field sensing and imaging.…”
Section: Discussionmentioning
confidence: 99%
“…Additional challenges biosensors incorporation in MPSs are scalability, biofouling, and reliability that should be addressed. [ 234 ] The combination of active materials and off‐chip detection systems that exclude the use of invasive probes could be a viable option. For example, nitrogen‐vacancy centers (NV) in diamonds are used for noninvasive and noncontact broadband vector magnetic field sensing and imaging.…”
Section: Discussionmentioning
confidence: 99%
“…[113,114] To enable in-line monitoring of adipose tissue secretions, on-chip sensors based on different technologies could be integrated. [44,46,115,116] To set up the WAT model, we established protocols and processes that allow to source all the different cell types from one individual donor; more specifically, from tissue samples of subcutaneous adipose tissue with skin that are readily available in most hospitals. The choice of a human cell source is an integral part for human-centered research.…”
Section: Discussionmentioning
confidence: 99%
“…[ 113 , 114 ] To enable in‐line monitoring of adipose tissue secretions, on‐chip sensors based on different technologies could be integrated. [ 44 , 46 , 115 , 116 ]…”
Section: Discussionmentioning
confidence: 99%
“…In the future, technological refinements could aim at scale-up and sensor integration: To achieve parallelized platforms with increased throughput, a combination with enabling technologies might be worthwhile; e.g., the WAT-on-chip design could be transferred to the organ-on-disc platform (Schneider et al, 2020;Stefan Schneider et al, 2021). To enable in-line monitoring of adipose tissue secretions, on-chip sensors based on different technologies could be integrated (Fuchs et al, 2021;Hu et al, 2020;Zhu et al, 2018Zhu et al, , 2021.…”
Section: Discussionmentioning
confidence: 99%